Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
20.53
+0.52 (2.60%)
Mar 10, 2026, 1:54 PM CST

Nanjing Vazyme Biotech Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Cash & Equivalents
-434.251,9671,5451,478
Upgrade
Trading Asset Securities
-2,2221,5141,7191,976
Upgrade
Cash & Short-Term Investments
2,7212,6563,4813,2643,454
Upgrade
Cash Growth
2.45%-23.69%6.65%-5.49%239.50%
Upgrade
Accounts Receivable
-483.61351.93839.62322.32
Upgrade
Other Receivables
-20.814.077.724.67
Upgrade
Receivables
-504.42356.01847.35326.99
Upgrade
Inventory
-362.18346.25364.2242.19
Upgrade
Prepaid Expenses
-0.05---
Upgrade
Other Current Assets
-48.5847.1289.7128.1
Upgrade
Total Current Assets
-3,5714,2304,5654,051
Upgrade
Property, Plant & Equipment
-726.07767.3679.48308.98
Upgrade
Long-Term Investments
-54.8347.322.3118.48
Upgrade
Goodwill
-130.49130.49130.49-
Upgrade
Other Intangible Assets
-95.19101.2449.716.65
Upgrade
Long-Term Accounts Receivable
-0.15---
Upgrade
Long-Term Deferred Tax Assets
-146.04106.5167.1224.87
Upgrade
Long-Term Deferred Charges
-278.91280.54318.31145
Upgrade
Other Long-Term Assets
-45.5182.53172.6942.25
Upgrade
Total Assets
-5,0495,7466,0054,607
Upgrade
Accounts Payable
-90.4146.82318.78118.76
Upgrade
Accrued Expenses
-129.74112.52258.07104.7
Upgrade
Short-Term Debt
-551.321,134272.21-
Upgrade
Current Portion of Leases
-57.0346.1658.2531.25
Upgrade
Current Income Taxes Payable
-0.60.030.5420.02
Upgrade
Current Unearned Revenue
-54.8755.92214.5595.03
Upgrade
Other Current Liabilities
-19.3624.0931.6717.5
Upgrade
Total Current Liabilities
-903.331,5201,154387.26
Upgrade
Long-Term Leases
-143.36106.89127.6859.93
Upgrade
Long-Term Unearned Revenue
-48.3821.3819.2516.24
Upgrade
Long-Term Deferred Tax Liabilities
-1.261.5111.190.87
Upgrade
Other Long-Term Liabilities
-8.7267.680.9215.52
Upgrade
Total Liabilities
-1,1051,7171,393479.83
Upgrade
Common Stock
-402.13400.01400.01400.01
Upgrade
Additional Paid-In Capital
-2,5122,4422,4292,422
Upgrade
Retained Earnings
-1,1391,2091,7801,305
Upgrade
Treasury Stock
--104.4-20.01--
Upgrade
Comprehensive Income & Other
--3.97-1.72--
Upgrade
Total Common Equity
3,8443,9454,0294,6094,127
Upgrade
Minority Interest
--1.63-0.113.2-
Upgrade
Shareholders' Equity
3,8413,9444,0294,6124,127
Upgrade
Total Liabilities & Equity
-5,0495,7466,0054,607
Upgrade
Total Debt
861.49751.711,287458.1491.18
Upgrade
Net Cash (Debt)
1,8601,9052,1942,8063,362
Upgrade
Net Cash Growth
-2.35%-13.19%-21.81%-16.56%230.91%
Upgrade
Net Cash Per Share
4.385.265.577.039.27
Upgrade
Filing Date Shares Outstanding
704.74397.82397400.01400.01
Upgrade
Total Common Shares Outstanding
704.74397.82397400.01400.01
Upgrade
Working Capital
-2,6682,7113,4113,664
Upgrade
Book Value Per Share
10.499.9210.1511.5210.32
Upgrade
Tangible Book Value
3,6243,7203,7984,4294,111
Upgrade
Tangible Book Value Per Share
9.899.359.5711.0710.28
Upgrade
Machinery
-712.88656.11513.97250.31
Upgrade
Construction In Progress
-69.42127.4869.44-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.